Metagenomi Therapeutics MGX
NASDAQ MGX
$1.10 -0.03 (-2.68%)
As of: Sep 30, 2026 · 1:46 PM EDT

Metagenomi Therapeutics, Inc. (MGX) Market Capitalization (2024 - 2026)

Updated

Metagenomi Therapeutics (MGX) reported Market Capitalization of $44.95 million for Q2 2026, down 19.1% from $55.55 million a year earlier and down 10.9% from the prior quarter.

Analysis

Metagenomi Therapeutics, Inc. (MGX) Market Capitalization (2024 - 2026) Analysis & Trends

For FY2025, Metagenomi Therapeutics posted Market Capitalization of $60.95 million, down 54.9% from FY2024.

  • By year, Market Capitalization came in at $135.08 million in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly Market Capitalization in data going back to Q1 2024.
  • Year over year, Market Capitalization has now declined in each of the last three quarters, with an average decline of 34.3% over the last six quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $50.45 million (Q1 2026), $60.95 million (Q4 2025) and $88.99 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.95 Mn
Mar 31, 2026 50.45 Mn
Dec 31, 2025 60.95 Mn
Sep 30, 2025 88.99 Mn
Jun 30, 2025 55.55 Mn
Mar 31, 2025 50.84 Mn
Dec 31, 2024 135.08 Mn
Sep 30, 2024 81.23 Mn
Jun 30, 2024 152.84 Mn
Mar 31, 2024 223.00 Mn
API Access

Metagenomi Therapeutics, Inc. Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=MGX&period=max&api_key=YOUR_API_KEY